LEHI, UT, March 29, 2007 — XANGO, LLC Co-Founder and Chief Marketing Officer Gordon Morton today announced the company has created a new formula, which will be marketed under the brand name, XALO^™ Juice (pronounced zay-lo) and introduced this summer in Europe.  Morton said XALO Juice, a proprietary fusion of aloe with mangosteen and other premium ingredients, expands XANGO’s leadership of the mangosteen supplement category, which the company created in 2002.  Sales of XANGO^® Juice, the company’s flagship product, continue to surge worldwide.

“XANGO’s exclusive XALO Juice formula combines the acclaim of aloe with our fresh mangosteen discovery to offer consumers a combination of great taste and vibrant nutritional benefits in a complete and complex functional beverage,” said Morton.  “XALO Juice arrives with this exceptional formula as a distinctly branded premium product.”

XANGO will introduce XALO Juice in the pilot markets of Germany, Belgium and Austria this summer (see www.xalojuice.com).

“XANGO has received a phenomenal reception by the German people since we introduced our flagship product, XANGO Juice, in Germany last fall,” said Morton. “Growth of our German distributors is far ahead of projections.  The introduction of XALO Juice empowers XANGO to expand the reach of the mangosteen category and meet the growing demands of the German market.”

In addition to the primary ingredients of aloe and mangosteen, XALO Juice contains grape seed and green tea. Through this proprietary blend of some of the world’s most celebrated botanicals, consumers may receive the following nutritional and antioxidant benefits with XALO Juice: support of digestive health and cleansing; revitalization and regeneration of healthy skin; improvement in proper absorption of vital nutrients; and a boost of natural energy levels.  The recommended daily intake of XALO Juice is 1-3 ounces.

Morton said XALO Juice fits seamlessly into XANGO’s pricing model and compensation plan. XALO Juice will be sold by the case – four 750ml bottles.

No related posts.